SRNE

STI-1499 (COVI-GUARD™)

COVID-19

Phase 1

Exp Date

Q4 2020 (Est)

Amp Volatility Score

Catalyst Info & Data Links

TITLE: VIR-7831 in COVID - Phase 1

  • ClinicalTrial.gov (NCT04454398): Study to Evaluate STI-1499 (COVI-GUARD) in Patients With Moderate COVID-19

WHAT IS THE CATALYST EVENT?

  • Phase 1


WHEN WILL THE EVENT (OR DID THE EVENT) OCCUR?

  • TBD


PRIOR DATA

PRESS RELEASES

PRESENTATIONS

MECHANISM OF ACTION / RATIONALE

  • STI-1499 (COVI-GUARD™), a COVID-19 targeting monoclonal antibody

Updated by HC

#SRNE, #STI1499

Prior Data (click to view full image)

Chart

Trial Design / Revenue (click to view full image)

Chart

Recent Posts

See What The Community Is Saying - Click To See Full Post

*Disclaimer: Information provided on ampbiotechresearch.com and in any of our reports, products and services are for information only and are not investment advice. Please consult with an investment adviser and do your own diligence before making any investment decisions or taking any action.  By accessing this site, you agree to our Terms of Use and Privacy Policy that can be accessed here. Amp Core™ is a trademark of Amp Biotech Research, LLC

©2020 BY Amp Biotech Research

  • Twitter Social Icon
  • LinkedIn Social Icon